Experimental Alzheimer’s drug may have contributed to death of study participant according to reports
A monoclonal antibody treatment for Alzheimers disease that showed promise in a Phase 3 trial may have contributed to a study participants death, according to an adverse events report obtained by the… [read more]
Living With Alzheimer’s Disease
Understanding Alzheimer’s Disease